Oral Ibrexafungerp Outcomes in Subjects With Refractory Vulvovaginal Candidiasis From an Open-Label Study (FURI) [A122].
Saved in:
| Title: | Oral Ibrexafungerp Outcomes in Subjects With Refractory Vulvovaginal Candidiasis From an Open-Label Study (FURI) [A122]. |
|---|---|
| Authors: | Goje, Oluwatosin1 (AUTHOR), King, Thomas (AUTHOR), Angulo, David (AUTHOR), Azie, Nkechi (AUTHOR) |
| Source: | Obstetrics & Gynecology. 2022 Supplement, Vol. 139, p36S-36S. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00297844 |
|---|---|
| DOI: | 10.1097/01.AOG.0000825768.79961.5b |
